novo nordisk obesity news - Search News

Novo Nordisk, Health Canada

Reuters on MSN · 19h

Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults, the Danish drugmaker said on Wednesday.

Pharmaceutical Technology · 2h

Health Canada approves Novo Nordisk’s Wegovy to cut heart attacks

Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, to reduce the risk of non-fatal myocardial infarction (MI).

cbc.ca on MSN · 16h

Health Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults

Global News · 22h

Wegovy approved in Canada to combat risk of non fatal-heart attack

Health Canada has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults.

Novo, Lilly shares rise

Novo, Lilly shares rise as Biden proposes obesity care coverage

Shares of Danish weight-loss drug maker Novo Nordisk rose 1.3% on Tuesday as U.S. President Joe Biden proposed expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid.

USA Today · 1d

Biden proposes Medicare, Medicaid cover pricey weight-loss drugs for obese Americans

Millions of Americans could soon have access to weight-loss medications that some have called "miracle drugs."

Bloomberg on MSN · 1d

Biden Proposal to Cover Obesity Drugs Sets Up Quandary for Trump

The Biden administration is proposing a rule that would require the US government to cover obesity drugs for millions of Americans, teeing up a financial and political challenge for President-elect Donald Trump as he prepares to take office.

Wall Street Journal on MSN1d

Novo Nordisk Says White House Obesity Plan Is Step in Right Direction

Novo Nordisk is encouraged by White House proposals that could support patients using weight-loss drugs, but cautioned ...

Bloomberg L.P.2d

Novo Nordisk Foundation Targets US, Europe After Obesity Boost

The Novo Nordisk Foundation’s assets have swelled with the success of diabetes and obesity treatments Ozempic and ...

3d

Novo Nordisk: Can CagriSema Show 25% Weight Loss In REDEFINE-1 Trial?

Novo Nordisk will report the topline results from the REDEFINE-1 trial of CagriSema in obese patients before the end of the ...

6don MSN

Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices

According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, ...

8don MSN

Is Novo Nordisk Stock a Buy Right Now?

Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.

2d

Novo Nordisk: Supply Strains, Competition, And RFK Concerns Mask Solid Fundamentals

Novo Nordisk faces challenges in weight-loss sector, but acquisition and strong diabetes portfolio position it for future ...

1d

Novo Nordisk Foundation CEO dismisses ‘Nokia risk’ as ‘fundamentally different’ for Denmark’s economy

Novo Nordisk Foundation CEO Mads Krogsgaard Thomsen said only 9 million people are using GLP-1s compared with 1 billion ...

1don MSN

Novo Nordisk shares rise as Biden proposes obesity care coverage

COPENHAGEN (Reuters) -Shares of Danish weight-loss drug maker Novo Nordisk rose 1.3% on Tuesday as U.S. President Joe Biden ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results